MedApp (WAR:MDA) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDA MedApp SA WAR:MDA
42 GF Score
Price zł0.20
GF Value zł0.24
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is MedApp FFO per Share?

FFO per Share only applies to REITs.

WAR:MDA
42GF Score
MedApp SA WAR:MDA
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MedApp (WAR:MDA) Overvalued in 2026?

Based on GuruFocus' analysis, MedApp stock appears to be undervalued. The current stock price of zł0.20 is trading 16.9% below its estimated GF Value™ of zł0.24. GuruFocus considers MedApp to be Modestly Undervalued.

Key valuation signals for WAR:MDA:

  • FFO per Share:
  • GF Value™: zł0.24 vs. price of zł0.20 (16.9% below fair value)
  • GF Score™: 42/100 with 5 warning signs

No single metric tells the full story. See the WAR:MDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedApp Business Description

Address Dobre Pasterza 122A, Krakow, POL, 31-416
MedApp SA develops mobile solutions for medicine. The company's products include Carna Life and Holo.
42GF Score

Get the complete analysis for WAR:MDA

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.20
Price
zł0.24
GF Value